Kymera Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Watertown, MA
KYMR chart
What traders are saying about $KYMR
Latest postsKymera Therapeutics, Inc. news
- Kymera Therapeutics (NASDAQ:KYMR) Stock Price Target Raised at Morgan Stanley
MarketBeat ·
- Kymera Therapeutics (KYMR) Could Be 17% Undervalued Following Its Earnings Preview
Simply Wall Street ·
- Could You Have Seen The Run In Kymera Stock Coming?
trefis.com ·
- Will Axsome Therapeutics (AXSM) Report Negative Earnings Next Week? What You Should Know
Yahoo Finance ·
- Kymera Therapeutics to present data from ongoing Phase 1 trial of KT-333
TipRanks ·
- Kymera Therapeutics, Inc. Estimates – NASDAQ:KYMR
TradingView ·
- Kymera Therapeutics (KYMR) Expected to Post Quarterly Earnings on Thursday
MarketBeat ·
- Kymera Therapeutics (NasdaqGM:KYMR) Stock Forecast & Analyst Predictions
Simply Wall Street ·
- Kymera Therapeutics to report Q3 2026 financial results on October 29, 2026
Pluang ·
- Kymera Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026
Yahoo Finance ·
- Kymera Therapeutics (NDQ:KYMR) Has Proven It Can Destroy Proteins. Can It Build Blockbuster Medicines?
Stocks Down Under ·
- Can KYMR's Targeted Protein Degradation Pipeline Drive Future Growth?
Yahoo Finance ·
Kymera Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $39.2M | $47.1M | $78.6M | $46.8M |
| Net income | $311.4M | $223.9M | $147.0M | $154.8M |
| Diluted EPS | $-3.69 | $-2.98 | $-2.52 | $-2.87 |
| Total assets (year end) | $1.74B | $978.0M | $575.8M | $603.1M |
| Cash and equivalents (year end) | $357.0M | $120.3M | $110.0M | $68.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Kymera Therapeutics, Inc.
- Ticker
- KYMR (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Watertown, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1815442
- Former names
- Kymera Therapeutics, Inc.
Frequently asked questions
What exchange is Kymera Therapeutics, Inc. listed on?
Kymera Therapeutics, Inc. trades on the Nasdaq under the ticker symbol KYMR.
What industry is Kymera Therapeutics, Inc. in?
Kymera Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Kymera Therapeutics, Inc. headquartered?
Kymera Therapeutics, Inc.'s business address on file with the SEC is in Watertown, MA.
When does Kymera Therapeutics, Inc.'s fiscal year end?
Kymera Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Kymera Therapeutics, Inc. report?
Kymera Therapeutics, Inc. reported $39.2M in revenue for calendar year 2025, according to its SEC filings.